EUVIMEDEUVIMED entdecken
Open Access

ER-export and ARFRP1/AP-1–dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication

Guy J Pearson iD, Harriet V Mears iD, Malgorzata Broncel iD, Ambrosius P Snijders, David L V Bauer iD, Jeremy G Carlton iD

Science Advances · 05.04.2024 · 10 (14)

DOI: 10.1126/sciadv.adl5012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 05.04.2024. Verfasst von Guy J Pearson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Organelle Dynamics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the global COVID-19 pandemic. Coronaviral Envelope (E) proteins are pentameric viroporins that play essential roles in assembly, release, and pathogenesis. We developed a nondisruptive tagging strategy for SARS-CoV-2 E and find that, at steady state, it localizes to the Golgi and to lysosomes. We identify sequences in E, conserved across Coronaviridae , responsible for endoplasmic reticulum–to–Golgi export, and relate this activity to interaction with COP-II via SEC24. Using proximity biotinylation, we identify an ADP ribosylation factor 1/adaptor protein–1 (ARFRP1/AP-1)–dependent pathway allowing Golgi-to-lysosome trafficking of E. We identify sequences in E that bind AP-1, are conserved across β-coronaviruses, and allow E to be trafficked from Golgi to lysosomes. We show that E acts to deacidify lysosomes and, by developing a trans-complementation assay for SARS-CoV-2 structural proteins, that lysosomal delivery of E and its viroporin activity is necessary for efficient viral replication and release.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansViral Envelope ProteinsTranscription Factor AP-1PandemicsVirus ReplicationLysosomesADP-Ribosylation Factors

Substanzen

Viral Envelope ProteinsTranscription Factor AP-1ARFRP1 protein, humanADP-Ribosylation Factors

Autor:innen und Institutionen

  • Organelle Dynamics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • School of Cancer & Pharmaceutical Sciences, King's College London, Great Maze Pond, London SE1 1UL, UK.
  • RNA Virus Replication Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Proteomic Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

ORCID-Profile: Guy J Pearson, Harriet V Mears, Malgorzata Broncel, David L V Bauer, Jeremy G Carlton

Förderung

  • Wellcome Trust

Zitieren

APA

Pearson, G. J., Mears, H. V., Broncel, M., Snijders, A. P., Bauer, D. L. V., & Carlton, J. G. (2024). ER-export and ARFRP1/AP-1–dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication. Science Advances, 10(14). https://doi.org/10.1126/sciadv.adl5012

Vancouver

Pearson GJ, Mears HV, Broncel M, Snijders AP, Bauer DLV, Carlton JG. ER-export and ARFRP1/AP-1–dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication. Science Advances. 2024;10(14). doi:10.1126/sciadv.adl5012

BibTeX
@article{Pearson2024,
  author = {Pearson, Guy J and Mears, Harriet V and Broncel, Malgorzata and Snijders, Ambrosius P and Bauer, David L V and Carlton, Jeremy G},
  title = {ER-export and ARFRP1/AP-1–dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {14},
  doi = {10.1126/sciadv.adl5012}
}
Kostenlos starten →